Fluence Corporation Ltd has unveiled its Aspiral™ family of decentralized, smart packaged wastewater treatment systems, based on its membrane aerated biofilm reactor (MABR) technology.
Fluence MABR is a spirally wound, self-respiring membrane that provides aeration for the wastewater process and functions as the biological reactor.
The Aspiral is a modular system said to reduce aeration energy consumption by up to 90% compared with conventional wastewater treatment methods. It is suitable for small- to medium-sized installations serving small towns, villages, residential communities, resorts, hotels and commercial complexes.
The Aspiral family offers several models, with treatment capacities per unit ranging from 20-350 m3/day (5,200- 92,000 GPD), depending on effluent requirements and design temperature. Containers may also be connected in parallel to handle larger effluent flows. The Aspiral L3, which treats up to 300 m³/day (80,000 GPD) of raw municipal wastewater, is equipped with all internal air and wastewater piping and arrives ready for fast installation and start-up. The Aspiral S1 and M2 models treat up to 50 m³/day (14,000 GPD) and 115 m³/day (30,000 GPD) of wastewater and include internal clarifiers, integral pre-treatment screen and arrive fully equipped and ready for fast installation and start-up. Fluence reports that the systems have been designed and field tested to produce Class 1A (China) and Title 22 (US) quality effluent for reuse through an enhanced nutrient removal process, can be monitored and controlled remotely, require minimal maintenance and are designed for future expansion due to their modular nature.
